H Cyte Inc Stock EBITDA
H CYTE Inc fundamentals help investors to digest information that contributes to H CYTE's financial success or failures. It also enables traders to predict the movement of MDVX OTC Stock. The fundamental analysis module provides a way to measure H CYTE's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to H CYTE otc stock.
MDVX |
H CYTE Inc OTC Stock EBITDA Analysis
H CYTE's EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
Current H CYTE EBITDA | (7.22 M) |
Most of H CYTE's fundamental indicators, such as EBITDA, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, H CYTE Inc is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
CompetitionAccording to the company disclosure, H CYTE Inc reported earnings before interest,tax, depreciation and amortization of (7.22 Million). This is 100.82% lower than that of the Healthcare sector and 101.12% lower than that of the Medical Devices industry. The ebitda for all United States stocks is 100.19% higher than that of the company.
MDVX EBITDA Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses H CYTE's direct or indirect competition against its EBITDA to detect undervalued stocks with similar characteristics or determine the otc stocks which would be a good addition to a portfolio. Peer analysis of H CYTE could also be used in its relative valuation, which is a method of valuing H CYTE by comparing valuation metrics of similar companies.H CYTE is currently under evaluation in ebitda category among related companies.
MDVX Fundamentals
| Return On Equity | -171.59 | |||
| Return On Asset | -65.35 | |||
| Operating Margin | 976.89 % | |||
| Current Valuation | 37.71 M | |||
| Shares Outstanding | 98.89 M | |||
| Shares Owned By Insiders | 4.26 % | |||
| Shares Owned By Institutions | 0.02 % | |||
| Number Of Shares Shorted | 253.31 K | |||
| Price To Earning | (2.09) X | |||
| Price To Book | 3.99 X | |||
| Price To Sales | (52.35) X | |||
| Revenue | (760.35 K) | |||
| Gross Profit | 315.42 K | |||
| EBITDA | (7.22 M) | |||
| Net Income | (8.74 M) | |||
| Cash And Equivalents | 2.59 M | |||
| Cash Per Share | 0.03 X | |||
| Total Debt | 1.92 M | |||
| Debt To Equity | 21.00 % | |||
| Current Ratio | 0.93 X | |||
| Book Value Per Share | 0.10 X | |||
| Cash Flow From Operations | (5.15 M) | |||
| Short Ratio | 5.33 X | |||
| Earnings Per Share | (0.24) X | |||
| Market Capitalization | 39.8 M | |||
| Total Asset | 11.53 M | |||
| Retained Earnings | (8.63 M) | |||
| Working Capital | 1.19 M | |||
| Current Asset | 1.77 M | |||
| Current Liabilities | 589.88 K | |||
| Z Score | 12.0 |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| C | Citigroup | |
| CRM | Salesforce | |
| MSFT | Microsoft |
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be tightly coupled with the direction of predictive economic indicators such as signals in real. You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.
Other Consideration for investing in MDVX OTC Stock
If you are still planning to invest in H CYTE Inc check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the H CYTE's history and understand the potential risks before investing.
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine |